Publications by authors named "Sarah Walinsky"

Claim this Profile
R
Regulatory considerations for successful implementation of digital endpoints in clinical trials for drug development.
Gül Erdemli, Tina Murphy, Sarah Walinsky

NPJ Digit Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA's Limited Population Pathway for Antibacterial and Antifungal Drugs.
Sumathi Nambiar, Sarah Walinsky, Katherine Schumann

Clin Pharmacol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis